Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-17 Purchase | 2021-08-18 6:20 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,750 | $2.73 | $10,238 | 94,865 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-31 Option Award | 2022-01-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,623 | $1.6575 | 98,859 (Direct) | View |
| 2021-08-23 Gift | 2021-09-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 1,851 | $0 | 95,236 (Indirect) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,391 | $1.9465 | 91,115 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-04 4:48 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.4521 | 237,724 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:48 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0 | 237,724 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:35 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.448 | 82,724 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0 | 150,000 (Direct) | View |